Contraceptive Provision to Adolescent Females Prescribed Teratogenic Medications
CONCLUSIONS:
Our data demonstrate female adolescents prescribed teratogens receive inadequate contraception provision, which could increase their risk for negative pregnancy outcomes. Although the presence of a federal risk mitigation system appears to improve contraceptive provision, these systems are costly and, in some instances, difficult to implement. Efforts to improve provider practices are needed.
Source: PEDIATRICS - Category: Pediatrics Authors: Stancil, S. L., Miller, M., Briggs, H., Lynch, D., Goggin, K., Kearns, G. Tags: Adolescent Health/Medicine, Contraception, Pharmacology, Therapeutics Article Source Type: research
More News: Absorica | Accutane | Brain | Cancer & Oncology | Dermatology | Diazepam | Drugs & Pharmacology | Electronic Medical Records (EMR) | Enalapril | Girls | Health | Hematology | Men | Methotrexate | Neurology | Pediatrics | Pregnancy | Skin | Statistics | Study | Topamax | Valium | Women